 |
|
|
| |
STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF is Safe and Well-Tolerated with Efficacy Comparable to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96
|
| |
| |
Reported by Jules Levin
4th International Workshop on HIV and Women, from Adolescence through Menopause
January 13-14, 2014 Washington DC, USA
C Creticos1, C McDonald2, S Segal-Maurer3, I Brar4, B Wade5, C Brinson6, W Garner7, D Porter7, T Fralich7, J DeMorin7, O Lugo-Torres7, E Elbert7
1Howard Brown Health Center, Chicago, IL; 2Tarrant County Infectious Disease, Fort Worth, TX, USA; 3New York Hospital Queens, Flushing, NY, USA; 4Henry Ford Hospital, Detroit, MI, USA; 5Center for Prevention/Treatment, Pensacola, FL, USA; 6Red River Family Practice, Austin, TX, USA; 7Gilead Sciences, Foster City, CA, USA
|
| |
|
|
|
|
|
